SteriPlas uses Premium Cold Plasma to penetrate biofilms, destroy resistant bacteria,1 and accelerate healing2,3 more effectively than standard therapies.
The challenge lies in infection
Resistant bacteria, often shielded within biofilm or hidden in hard-to-reach areas, remain out of reach of standard antibiotics and topical therapies.
While infection persists, your patients healing is delayed, recovery is prolonged, antibiotic resistance increases, risks escalate, and the cycle continues.
Biofilm can make bacteria up to 1000× more antibiotic resistant4
Poor blood flow limits systemic antibiotics effectiveness5
Topical therapies can’t penetrate biofilm or deep tissue6
SteriPlas breaks the cycle of infection
SteriPlas Premium Cold Plasma penetrates infection sites with precision, destroying all bacteria types,1 even those hidden in biofilm, to accelerate healing,2,3 protect recovery, and reduce the risk of escalation.
Speak to a representative
Clinically proven to deliver exceptional results
73.5%
Reduced load
Clinically proven to reduce bacterial load by 73.5%.1
100
Size reduction
Documented reduction of up to 100% wound size.7
100
Depth reduction
Documented reduction of up to 100% wound depth.7
Break the cycle of infection
Manage infections with confidence with Premium Cold Plasma, proven to destroy resistant bacteria1 where other therapies fail.
01/
Tackling infection where others can’t
Penetrates wounds and hard-to-reach sites to destory all bacterial types,1 including those hidden in biofilm.
02/
Advanced Premium Cold Plasma
Powerful, high-density plasma penetrates tissue deeply, bombarding bacterial cells and rupturing their structure.
03/
The leading cold plasma therapy
18+ years of safe use, more than 10,000 treatments and over 85 peer-reviewed publications.8
04/
Safe and simple treatment
Delivered in a painless treatment that causes no harm to healthy tissue and avoids the risk of antibiotic resistance.8
Getting started is simple
01
Speak to a representative to check eligibility
Meet with our team and check if you’re eligible to evaluate.
02
Start a fully supported evaluation
Get full training, clinical support, and outcome tracking throughout.
03
Choose to lease or buy
Decide on the best funding route for your hospital.
References
1. Isbary G, Heinlin J, Shimizu T, et al. Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol. 2012;167(2):404-410. doi:10.1111/j.1365-2133.2012.10923.x
2. Heinlin J, Zimmermann JL, Zeman F, et al. Randomized placebo-controlled human pilot study of cold atmospheric argon plasma on skin graft donor sites. Wound Repair Regen Off Publ Wound Heal Soc Eur Tissue Repair Soc. 2013;21(6):800-807. doi:10.1111/wrr.12078
3. Isbary G, Stolz W, Shimizu T, et al. Cold atmospheric argon plasma treatment may accelerate wound healing in chronic wounds: Results of an open retrospective randomized controlled study in vivo. Clin Plasma Med. 2013;1(2):25-30. doi:10.1016/j.cpme.2013.06.001
4. Zhao A, Sun J, Liu Y. Understanding bacterial biofilms: From definition to treatment strategies. Front Cell Infect Microbiol. 2023;13:1137947. doi:10.3389/fcimb.2023.1137947
5. Jager NGL, van Hest RM, Lipman J, Roberts JA, Cotta MO. Antibiotic exposure at the site of infection: principles and assessment of tissue penetration. Expert Rev Clin Pharmacol. 2019;12(7):623-634. doi:10.1080/17512433.2019.1621161
6. Stuermer EK, Plattfaut I, Dietrich M, et al. In vitro Activity of Antimicrobial Wound Dressings on P. aeruginosa Wound Biofilm. Front Microbiol. 2021;12. doi:10.3389/fmicb.2021.664030
7. Moelleken M, Jockenhöfer F, Wiegand C, Buer J, Benson S, Dissemond J. Pilot study on the influence of cold atmospheric plasma on bacterial contamination and healing tendency of chronic wounds. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2020;18(10):1094-1101. doi:10.1111/ddg.14294
8. Data on file.